Search Results
AML data at ASH 2021 and implications on clinical practice
Novel treatment paradigms for AML at ASH 2021
FLT3-mutated AML data at ASH 2021
Understanding and addressing disparities in AML clinical trials | Andrew Hantel, MD | ASH 2021 #AML
ASH Clinical Practice Guidelines on Acute Myeloid Leukemia (AML) In Older Adults
Advancing the treatment of MDS and AML: An update from ASH 2021
AML Treatment Challenges Who, When, and How
Novel Therapies in Myeloid Neoplasms
Targeted Therapies in AML
Abby Statler: Are Clinical Trials Exclusion Criteria for AML Too Strict?
Treating patients with poor-risk cytogenetics with venetoclax and HMAs
The development of clinical guidelines for older patients with AML
